Prostate Cancer Reports
54

Volume 5 Supplement 6
June 2017


Home > Prostate Cancer Reports > Volume 5, Year 2017 > Supplement 6, June


CONTENTS



CASE REPORTS
CLASSIFICATION
DIAGNOSIS AND EVALUATION
EPIDEMIOLOGY, RISK FACTORS AND PREVENTION
ETIOLOGY, PATHOGENESIS AND PATHOLOGY
FOLLOW-UP AND QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS AND OUTCOMES
TREATMENT



CASE REPORTS






CLASSIFICATION




DIAGNOSIS AND EVALUATION



van Leeuwen PJ, Stricker P, Hruby G, Kneebone A, Ting F, Thompson B, Nguyen Q, Ho B, Emmett L.
(68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment.
BJU Int. 2016 May;117(5):732-9. doi: 10.1111/bju.13397. Epub 2016 Jan 24.
Source | Abstract | Full text | Similar articles



EPIDEMIOLOGY, RISK FACTORS AND PREVENTION






ETIOLOGY, PATHOGENESIS AND PATHOLOGY






FOLLOW-UP AND QUALITY OF LIFE



Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi NC, Reuter C, Bodis S, Kaouthar K, Wust P, Thalmann GN, Aebersold DM.
Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10.
J Clin Oncol. 2015 Dec 10;33(35):4158-66. doi: 10.1200/JCO.2015.63.3529. Epub 2015 Nov 2.

Source | Abstract | Full text | Similar articles



INTEGRATIVE MEDICINE






OVERALL MANAGEMENT






PROGNOSIS AND OUTCOMES


<<<

Carrie C, Hasbini A, de Laroche G, Richaud P, Guerif S, Latorzeff I, Supiot S, Bosset M, Lagrange JL, Beckendorf V, Lesaunier F, Dubray B, Wagner JP, N'Guyen TD, Suchaud JP, Créhange G, Barbier N, Habibian M, Ferlay C, Fourneret P, Ruffion A, Dussart S.
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Lancet Oncol. 2016 Jun;17(6):747-56. doi: 10.1016/S1470-2045(16)00111-X. Epub 2016 May 6.

Source | Abstract | Full text | Similar articles




Freedland SJ, Choeurng V, Howard L, De Hoedt A, du Plessis M, Yousefi K, Lam LL, Buerki C, Ra S, Robbins B, Trabulsi EJ, Shah NL, Abdollah F, Feng FY, Davicioni E, Dicker AP, Karnes RJ, Den RB.
Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy.
Eur Urol. 2016 Oct;70(4):588-596. doi: 10.1016/j.eururo.2016.01.008. Epub 2016 Jan 21.

Source | Abstract | Full text | Similar articles



<<<

Tendulkar RD, Agrawal S, Gao T, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw SL, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ.
Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy.
J Clin Oncol. 2016 Aug 15. pii: JCO679647. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



TREATMENT



Müller AC, Zips D, Heinrich V, Lamprecht U, Voigt O, Burock S, Budach V, Wust P, Ghadjar P.
Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial.
Radiat Oncol. 2015 Jul 8;10:138. doi: 10.1186/s13014-015-0442-4.

Source | Abstract | Full text | Similar articles




Robinson BD, Epstein JI.
Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings.
J Urol. 2010 Oct;184(4):1328-33. doi: 10.1016/j.juro.2010.06.017. Epub 2010 Aug 17.
Source | Abstract | Full text | Similar articles







Source | Abstract | Full text |